Clinical Trials List
2024-12-01 - 2027-12-31
Phase I
Recruiting5
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hung-Chih Hsu Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳承翰 Division of Hematology & Oncology
- 楊陽生 Division of Hematology & Oncology
- YU-HSUAN SHIH Division of Hematology & Oncology
- Huey-En Tzeng Division of Hematology & Oncology
- HSIN-CHEN LIN Division of Hematology & Oncology
- ZHENG-WEI ZHOU Division of Hematology & Oncology
- Cheng-Lun Lai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
32 participants
-
Global
54 participants
